Live Breaking News & Updates on Apogee Therapeutics

Stay updated with breaking news from Apogee therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Artia Global Partners LP Makes New $290,000 Investment in Apogee Therapeutics, Inc. (NASDAQ:APGE)

Artia Global Partners LP bought a new position in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 10,381 shares of the company’s stock, valued at approximately $290,000. Apogee Therapeutics makes up approximately 0.1% of […] ....

New Zealand General , New Zealand , United States , Stifel Nicolaus , Apogee Therapeutics Inc , Jefferies Financial Group , Wellington Management Group , Vanguard Group Inc , Artia Global Partners , Apogee Therapeutics , Free Report , Management Group , Vanguard Group , Get Free Report , Financial Group , Apogee Therapeutics Daily ,

Artia Global Partners LP Acquires New Stake in Apogee Therapeutics, Inc. (NASDAQ:APGE)

Artia Global Partners LP acquired a new position in Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) during the 4th quarter, HoldingsChannel.com reports. The firm acquired 10,381 shares of the company’s stock, valued at approximately $290,000. Apogee Therapeutics makes up 0.1% of Artia Global Partners LP’s holdings, making the stock its 25th largest holding. Other large […] ....

United States , New Zealand General , New Zealand , Stifel Nicolaus , Jefferies Financial Group , Apogee Therapeutics Inc , Vanguard Group Inc , Wellington Management Group , Artia Global Partners , Apogee Therapeutics , Free Report , Management Group , Vanguard Group , Financial Group , Get Free Report , Visit Holdingschannel , Apogee Therapeutics Daily ,

Swiss National Bank Makes New $922,000 Investment in Apogee Therapeutics, Inc. (NASDAQ:APGE)

Swiss National Bank bought a new stake in shares of Apogee Therapeutics, Inc. (NASDAQ:APGE – Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 33,000 shares of the company’s stock, valued at approximately $922,000. Swiss National Bank owned approximately 0.07% of […] ....

New York , United States , Stifel Nicolaus , Vanguard Group Inc , China Universal Asset Management Co , Sg Americas Securities , York State Common Retirement Fund , Swiss National Bank , Jefferies Financial Group , Jennison Associates , Apogee Therapeutics Inc , Exchange Commission , Apogee Therapeutics , Free Report , National Bank , Universal Asset Management , Vanguard Group , Get Free Report , Visit Holdingschannel , Apogee Therapeutics Daily ,

CinCor's 'hub-and-spoke' parent nabs new funding to build its next biotechs

CinCor's 'hub-and-spoke' parent nabs new funding to build its next biotechs
biopharmadive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharmadive.com Daily Mail and Mail on Sunday newspapers.

United States , Cinfina Pharma , Cinphloro Pharma , Jon Isaacsohn , Cincor Pharma , Cindome Pharma , Puretech Health , Roivant Sciences , Dive Brief , Karuna Therapeutics , Apogee Therapeutics , Biopharma Dive , Phloro Pharma ,